Biocartis Group NV , an innovative molecular diagnostics company, today announces the publication in the renowned clinical oncology journal The Lancet Oncology of an important study[1] by Prof. Dr. Bart Neyns from the University Hospital in Brussels (Belgium). In this ...
Read More »Featured Exosome Job – Associate Director, Molecular Diagnostics
San Francisco, CA | Translational Medicine Job Summary This position will be responsible for biomarker discovery and diagnostic development for rucaparib and other Clovis programs. This positon will work effectively with Translational Medicine, Biostatistics, Clinical Development, Regulatory, Clinical Operation, and ...
Read More »Featured Exosome Job – Senior Project Manager, Molecular Diagnostics
Exosome Diagnostics is expanding our laboratories in the IZB in Martinsried. We are looking for a Senior Project Manager, experienced in medical devices/diagnostic development who can guide core teams through a regulated product development cycle, including CE marking and FDA ...
Read More »Exosome Diagnostics Raises $17.6 Million in Second Round Series B Financing
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, today announced the completion of an additional $17.6 million round of financing in an extension of its Series B financing, bringing the total Series B financing raise to ...
Read More »Researchers Catch the Exosome Express
from Genetic Engineering & Biotechnology News Exosomes are lipid nanovesicles secreted from cells and found in all bodily fluids such as plasma, urine, and cerebrospinal fluid. Originally viewed as garbage disposal systems for cellular debris and proteins, they are now ...
Read More »